Medeva

Medeva is engaged in developing pharmaceutical research products.

About Medeva

Medeva is a Healthcare company. Medeva is engaged in developing pharmaceutical research products. It operates on a Professional Services model. Medeva has completed 1 acquisition, including Hikma. Medeva offers products and services including Monoclonal Antibodies, PCR Assays, and Elisa Tests. Its focus areas include Biotechnology and Pharmaceutical Research.

Company details

Medeva is involved in the development and manufacturing of pharmaceutical research products. Focus areas include virology, PCR assays, Elisa tests, and antibodies such as monoclonal antibodies. The company contributes to advancements in cancer research, precision medicine, and vaccine design through innovative approaches like glycan engineering and next-generation antibodies. Solutions are tailored for biotechnology and therapeutic applications across various health sectors.

Key Metrics

Products & Services of Medeva

Medeva offers a comprehensive portfolio of products and services, including Monoclonal Antibodies, PCR Assays, and Elisa Tests.

Monoclonal Antibodies
Pharmaceutical Research

Monoclonal antibodies are developed for cancer research applications.

PCR Assays
Pharmaceutical Research

PCR assays are provided for virology research purposes.

Elisa Tests
Pharmaceutical Research

Elisa tests are manufactured for diagnostic research use.

Investments & Acquisitions by Medeva

Medeva has strategically engaged in corporate development activities, having acquired 1 company. Notable acquisitions include Hikma.

Acquisitions
Company NameDescriptionDomainLocationFoundedAcquiredAmount
Injectable and generic drugs are manufactured for pharmaceutical use.
ribosepharm.deMartinsried, Germany1978Jun 1993β€’β€’β€’β€’
Premium access

Complete acquisition details for Medeva

Acquired stakes, deal sources and the complete acquisition history require an active premium plan.

  • Acquired stakes
  • Deal sources
  • Complete history
  • Exports

Verified entity values are shown only after access is granted.

Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track β€” from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • βœ“
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • βœ“
    Full access to every database India & global coverage, advanced filters and rich profile details
  • βœ“
    Always-on access from your team account Single premium plan for everything you see on the portal

Frequently Asked Questions about Medeva

Medeva is involved in the development and manufacturing of pharmaceutical research products. Focus areas include virology, PCR assays, Elisa tests, and antibodies such as monoclonal antibodies. The company contributes to advancements in cancer research, precision medicine, and vaccine design through innovative approaches like glycan engineering and next-generation antibodies. Solutions are tailored for biotechnology and therapeutic applications across various health sectors.

Medeva offers Monoclonal Antibodies, PCR Assays, and Elisa Tests.

Medeva has made 1 acquisition, including Hikma.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available